Navigation Links
BioDiscovery Releases NEXUS CGH Version 2 for DNA Copy Number Analysis and Visualization
Date:10/16/2007

- Nexus CGH Gets Scientists 'Back to the Bench'-

EL SEGUNDO, Calif., Oct. 16 /PRNewswire/ -- BioDiscovery, Inc. the pioneering developer of integrated software solutions for microarray-based research, announced today the release of NEXUS CGH version 2, the first commercial software tool that provides easy, fast and powerful platform independent and cross-platform analysis of multiple array based DNA copy number data sets, simultaneously.

NEXUS CGH easily supports large-scale array experiments involving thousands of samples from any platform, including high-density multi-million probe SNP as well as two-color CGH arrays. Its user-friendly interface, allows the researcher to quickly identify potential regions of significant copy number changes in various biological categories and extract a gene list for the smallest region of overlap in the sample set.

"Using NEXUS CGH, my lab has been able to quickly and confidently process large amounts of high-density array CGH data obtained from FFPE tumor samples to identify important chromosomal regions," said Dr. Jeff Gregg head of Molecular Pathology at UC Davis. "NEXUS CGH has allowed us to move from raw data into exploring CNV's and associated genes in a matter of few hours whereas this process took months to complete with other commercial or academic packages."

Dr. Anjene Addington, Child Psychiatry Branch, NIMH, NIH said, "With Nexus CGH, we are able to quickly and easily identify key regions of interest and jump straight to relevant statistical tests and bioinformatics tools, making the whole process more efficient."

Nexus CGH version 2 is the only commercial package offering unique features such as statistical significance test of aberration frequencies, automatic identification of regions of significant statistical difference between sample groups, clustering samples based on genomic profile, and much more.

"We have received an overwhelmingly positive reception to Nexus CGH from leading research institutions including UCSF, Johns Hopkins, UCLA, NIH, The Norwegian Radium Hospital, UCD, Duke, City of Hope, Harvard, and Dundee University," said Dr. Soheil Shams, CEO, BioDiscovery, Inc. "Nexus CGH version 2 enables scientists to convert mountains of copy number data into actionable knowledge in a matter of minutes."

About BioDiscovery

BioDiscovery is a leader in the development of microarray advanced bioinformatics software and services that enable its customers to revolutionize drug discovery and diagnostics by efficiently managing, integrating, and analyzing data generated using high-throughput microarray technology. Contact us: 310-414-8100 or http://www.biodiscovery.com.


'/>"/>
SOURCE BioDiscovery, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Sweet corn releases antioxidants on cooking
2. An International Growth Standard For Childs Releases By WHO
3. The National Governors Association Releases Guidelines For Outbreak Of Bird Flu
4. Eli Lilly Releases Digital Insulin Pen
5. Nexus Between Psychiatrists and Drug Firms Dangerous, Say Critics
6. Sun Pharma to launch chiral version of omeprazole soon
7. Slimmer’s Delight: Potato Version 2, on a platte
8. Friends of Earth Protest water Diversion Project ,Garrison-II.
9. Latest Version of Echocardiography Provides Improved Pictures of the Heart
10. First Generic Version of Lexapro permitted by US
11. Sun Pharma Allots Shares Upon Fccbs Conversion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... ... ... crisis. Her son James, eight, was out of control. Prone to extreme mood shifts and ... him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife on ... say he was going to kill them. If we were driving on the freeway, ...
(Date:6/24/2016)... ... 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited to ... Recovery® program to drive cancer patients to and from their cancer treatments. Comfort ... quality of life and ongoing independence. Getting to and from medical treatments is ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
Breaking Medicine Technology: